Nights In The Forest is one of the most unique survival games on the Roblox platform, where you try to survive in a ...

GamingWithKev discusses why Space Jam 2 in Roblox remains a fun sports game. Audit Finds $1B in Improper Medicaid Payments China Retaliates After U.S. Imposes New Fees ...

FIRST ON FOX: Kentucky brought a civil lawsuit on Monday against Roblox alleging the massive gaming platform is not safe for children, joining a growing list of entities who have sued over similar ...

Roblox stock (NYSE: RBLX) has fallen 9% in the past five trading days, fueled by a Wall Street analyst’s pessimistic assessment—citing slowing booking growth—and insider selling by a company director.

Kentucky has sued Roblox, alleging that children are accessing violent simulation games on the popular gaming platform, including depictions of the assassination of Charlie Kirk, just weeks after the ...

FRANKFORT, Ky. (WDRB) -- Kentucky Attorney General Russell Coleman filed a lawsuit recently against Roblox Inc., accusing the gaming and social media platform of failing to protect children from ...

Kentucky is suing Roblox for allegedly allowing child predators to run rampant on its platform and exposing children to heinous material — including simulators of conservative activist Charlie Kirk’s ...

LOUISVILLE, Ky. (WDRB) -- Kentucky Attorney General Russell Coleman is suing the gaming and social media platform Roblox. In a lawsuit filed Monday, Coleman accuses Roblox of knowingly creating a ...

Kentucky Attorney General Russell Coleman announced Tuesday the commonwealth will sue online gaming platform Roblox, claiming it failed to prevent sex abuse and the grooming of minors. Oberon Copeland ...

Kentucky Attorney General Russell Coleman has sued Roblox, arguing the online gaming platform lacks adequate security and has exposed kids to child predators. Roblox pushed back in a statement, ...

Steven Goldstein is based in London and responsible for MarketWatch's coverage of financial markets in Europe, with a particular focus on global macro and commodities. Previously, he was Washington ...

CRISPR Therapeutics and BioNTech have climbed along with many of their peers over the past week. Both are innovative biotechs with catalysts that could drive their stocks higher in the next few years.